Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training

  • Heart Failure (W Tang, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Adult chronic heart failure (HF) is a terminal syndrome. While the HF phenotype is inhomogeneous across the ejection fraction spectrum, exercise intolerance remains a cardinal feature of all HF patients. Impairment of a single organ system cannot independently account for exercise intolerance in HF. Thus, the multi-system integrative pathophysiology of HF leads to challenges in identifying an effective medical therapy aimed at targeting a single mechanism to improve exercise tolerance. This unresolved medical care approach raises a number of points for discussion in this field as it is well-recognized that exercise intolerance is accompanied by increased hospitalizations and mortality across the HF spectrum. Practitioner-guided individualized exercise training represents an intrinsic multi-level therapeutic approach that inclusively “targets” integrated physiological systems. A rapidly evolving body of evidence provides firm support that structured exercise therapy is safe while leading to improved exercise tolerance (peak oxygen uptake [V̇O2]) followed by reduced hospitalizations and cardiovascular mortality across the HF spectrum. The benefits of guided exercise therapy in HF have been directly attributed to integrative improvements in peak V̇O2, skeletal muscle strength, cardiac function, micro- to macro-vascular function, circulation/organ perfusion, and nervous system function, among others. Despite the sound clinical evidence in support of exercise-based medical care, there remains an appreciable gap in translation of current scientific evidence and implementation of this therapeutic paradigm into routine clinical practice as well as universal insurance coverage for HF patients. In the following review, the theme of discussion is framed in a manner that carries a sense of urgency for the need to increase awareness of the up-to-date evidence-based support for the clinical implementation of structured exercise therapy as a necessary routine component of primary medical care practices for reducing hospitalizations, morbidity, and mortality in all HF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603. https://doi.org/10.1161/CIR.0000000000000485. Highlights key statistics relevant to understanding the magnitude of the global burden of heart failure

  2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19. https://doi.org/10.1161/HHF.0b013e318291329a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. •• Chamberlain AM, St Sauver JL, Gerber Y, Manemann SM, Boyd CM, Dunlay SM, et al. Multimorbidity in heart failure: a community perspective. Am J Med. 2015;128(1):38–45. https://doi.org/10.1016/j.amjmed.2014.08.024. Highlights the need for a better understanding of the clinical consequences of multiple chronic conditions in heart failure patients

  4. ••Ziaeian B, Heidenreich PA, Xu H, DeVore AD, Matsouaka RA, Hernandez AF et al. Race/ethnic differences in outcomes among hospitalized Medicare patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2017:5(7):483–93. Demonstrates differences in mortality and readmission risk for patients with HFpEF according to race/ethnicity as well as after adjusting for patient characteristics, SES, and hospital factors

  5. •• Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64(21):2281–93. https://doi.org/10.1016/j.jacc.2014.08.036. This review summarizes the role that noncardiac comorbidities play in patients with HFpEF versus HFrEF in understanding prevalence, underlying pathophysiologic mechanisms, and outcomes

  6. •• Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535–e78. https://doi.org/10.1161/CIR.0000000000000450. Summarizes recent data relevant to contributory risk and to provide guidance on the management of cardiovascular comorbidities in the development and prognosis of heart failure

  7. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996–1004.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tribouilloy C, Rusinaru D, Marechaux S. Heart failure with preserved ejection fraction: looking for new pieces of a complex puzzle. Arch Cardiovasc Dis. 2014;107(2):73–6. https://doi.org/10.1016/j.acvd.2014.01.006.

    Article  PubMed  Google Scholar 

  9. Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum Response to Borlaug and Redfield. Circulation. 2011;123(18):2006–14.

    Article  PubMed  PubMed Central  Google Scholar 

  10. •• Lund LH, Donal E, Oger E, Hage C, Persson H, Haugen-Löfman I, et al. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16(9):992–1001. Investigates and characterizes the prevalence and role of cardiovascular and non-cardiovascular co-morbidities relative to outcomes in patients with HFpEF

  11. • Van Iterson EH, Johnson BD, Borlaug BA, Olson TP. Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection heart failure. Eur J Heart Fail. 2017; https://doi.org/10.1002/ejhf.913. Demonstrates the primary integrative physiological determinants of exercise ventilatory inefficiency accompanied by exercise intolerance are not homogeneous across patients with HFrEF versus those with HFpEF

  12. •• Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. Updated guidelines from the ECS for the identification, diagnosis, and management of patients with HF

  13. •• Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 2017; https://doi.org/10.1161/CIR.0000000000000509. Updated guidelines from the AHA/ACC for the identification, diagnosis, and management of patients with HF

  14. • Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2014;306(9):H1364–70. https://doi.org/10.1152/ajpheart.00004.2014. Demonstrates skeletal muscle pathophysiology affecting reduced oxidative capacity may play a critical role in exercise intolerance in patients with HFpEF

  15. Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW. Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol. 2012;60(2):120–8. https://doi.org/10.1016/j.jacc.2012.02.055.

    Article  PubMed  PubMed Central  Google Scholar 

  16. • Van Iterson EH, Johnson BD, Joyner MJ, Curry TB, Olson TP. VO2 kinetics associated with moderate intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents. Am J Phys Heart Circ Phys. 2017;313(1):H114–24 https://doi.org/10.1152/ajpheart.00014.2017. Highlights the role that integrative central to peripheral organ pathophysiology plays in contributing to impaired oxidative capacity in patients with HFrEF. Pharmacologically reducing the influence of group III/IV muscle afferents during exercise leads to rapid VO2 kinetics and improved muscle oxidative capacity

  17. • Olson TP, Joyner MJ, Eisenach JH, Curry TB, Johnson BD. Influence of locomotor muscle afferent inhibition on the ventilatory response to exercise in heart failure. Exp Physiol. 2014;99(2):414–26. https://doi.org/10.1113/expphysiol.2013.075937. Demonstrates the high rate-mediated ventilation that occurs during exercise in patients with HFrEF contributes to maldistribution of blood flow away from metabolically active locomotors muscles towards respiratory muscles as a contributing mechanism to exercise intolerance

  18. Sperandio PA, Oliveira MF, Rodrigues MK, Berton DC, Treptow E, Nery LE, et al. Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure. Am J Physiol Heart Circ Physiol. 2012;303(12):H1474–80. https://doi.org/10.1152/ajpheart.00435.2012.

    Article  CAS  PubMed  Google Scholar 

  19. • Zamani P, Rawat D, Shiva-Kumar P, Geraci S, Bhuva R, Konda P, et al. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation. 2015;131(4):371–380; discussion 80. https://doi.org/10.1161/CIRCULATIONAHA.114.012957. Demonstrates cross-sectional supplementation of inorganic nitrate prior to exercise testing results in improved peak exercise hemodynamics and VO2 in patients with HFpEF

  20. • Borlaug BA, Koepp KE, Melenovsky V. Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2015;66(15):1672–82. https://doi.org/10.1016/j.jacc.2015.07.067. In a randomized double blind placebo controlled design, this study demonstrates cross-sectional supplementation of inorganic nitrite prior to exercise testing results in improved central hemodynamic mediated exercise capacity in patients with HFpEF

  21. Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1–17. https://doi.org/10.1097/HJR.0b013e3283313592.

    Article  PubMed  Google Scholar 

  22. •• Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail. 2015;8(1):33–40. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001615. Highlights the favorable role that structured practitioner supervised exercise training therapy has on improving exercise tolerance in patients with HFpEF

  23. Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011;13(4):347–57.

    Article  PubMed  Google Scholar 

  24. Kitzman DW, Brubaker PH, Herrington DM, Morgan TM, Stewart KP, Hundley WG, et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol. 2013;62(7):584–92. https://doi.org/10.1016/j.jacc.2013.04.033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Smart NA, Haluska B, Jeffriess L, Leung D. Exercise training in heart failure with preserved systolic function: a randomized controlled trial of the effects on cardiac function and functional capacity. Congest Heart Fail. 2012;18(6):295–301. https://doi.org/10.1111/j.1751-7133.2012.00295.x.

    Article  PubMed  Google Scholar 

  26. Alves AJ, Ribeiro F, Goldhammer E, Rivlin Y, Rosenschein U, Viana JL, et al. Exercise training improves diastolic function in heart failure patients. Med Sci Sports Exerc. 2012;44(5):776–85. https://doi.org/10.1249/MSS.0b013e31823cd16a.

    Article  PubMed  Google Scholar 

  27. Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (exercise training in diastolic heart failure) pilot study. J Am Coll Cardiol. 2011;58(17):1780–91. https://doi.org/10.1016/j.jacc.2011.06.054.

    Article  PubMed  Google Scholar 

  28. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010;3(6):659–67. https://doi.org/10.1161/CIRCHEARTFAILURE.110.958785.

    Article  PubMed  PubMed Central  Google Scholar 

  29. •• Nolte K, Herrmann-Lingen C, Wachter R, Gelbrich G, Dungen HD, Duvinage A, et al. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol. 2015;22(5):582–93. https://doi.org/10.1177/2047487314526071. Illustrates exercise training therapy for the management of HFpEF may lead to favorable effects on exercise tolerance accompanied by overall improvements of quality of life metrics

  30. Ismail H, McFarlane JR, Nojoumian AH, Dieberg G, Smart NA. Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysis. JACC Heart Fail. 2013;1(6):514–22. https://doi.org/10.1016/j.jchf.2013.08.006.

    Article  PubMed  Google Scholar 

  31. Du HY, Newton PJ, Zecchin R, Denniss R, Salamonson Y, Everett B, et al. An intervention to promote physical activity and self-management in people with stable chronic heart failure The Home-Heart-Walk study: study protocol for a randomized controlled trial. Trials. 2011;12:63. https://doi.org/10.1186/1745-6215-12-63.

    Article  PubMed  PubMed Central  Google Scholar 

  32. •• Piepoli MF, Binno S, Corra U, Seferovic P, Conraads V, Jaarsma T, et al. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. Eur J Heart Fail. 2015;17(6):631–8. https://doi.org/10.1002/ejhf.271. Presents data illustrating that despite the proposed benefits of exercise training programs for patients with HF, not all medical care centers demonstrate the ability to routinely offer this form of medical care to patients

  33. Kubinyi A, Bacior B, Szot W, Klecha A, Kawecka-Jaszcz K. Cardiopulmonary exercise test and heart rate variability in patients with congestive heart failure who underwent physical rehabilitation. Przeglad lekarski. 2002;60(11):732–6.

    Google Scholar 

  34. Giannuzzi P, Temporelli PL, Corra U, Tavazzi L, Group E-CS. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) trial. Circulation. 2003;108(5):554–9. https://doi.org/10.1161/01.CIR.0000081780.38477.FA.

    Article  PubMed  Google Scholar 

  35. Klecha A, Kawecka-Jaszcz K, Bacior B, Kubinyi A, Pasowicz M, Klimeczek P, et al. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling. Eur J Cardiovasc Prev Rehabil. 2007;14(1):85–91. https://doi.org/10.1097/HJR.0b013e3280114f12.

    Article  PubMed  Google Scholar 

  36. Silva MS, Bocchi EA, Guimaraes GV, Padovani CR, Silva MH, Pereira SF, et al. Benefits of exercise training in the treatment of heart failure: study with a control group. Arq Bras Cardiol. 2002;79(4):351–62.

    Article  PubMed  Google Scholar 

  37. Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 1992;85(6):2119–31.

    Article  CAS  PubMed  Google Scholar 

  38. Smart N, Haluska B, Jeffriess L, Marwick TH. Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life. Am Heart J. 2007;153(4):530–6. https://doi.org/10.1016/j.ahj.2007.01.004.

    Article  PubMed  Google Scholar 

  39. McKelvie RS, Teo KK, Roberts R, McCartney N, Humen D, Montague T, et al. Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). Am Heart J. 2002;144(1):23–30. https://doi.org/10.1067/mhj.2002.123310.

    Article  PubMed  Google Scholar 

  40. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309(12):1268–77. https://doi.org/10.1001/jama.2013.2024.

    Article  CAS  PubMed  Google Scholar 

  41. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, et al. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet. 2000;356(9230):615–20.

    Article  CAS  PubMed  Google Scholar 

  42. Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013;309(8):781–91. https://doi.org/10.1001/jama.2013.905.

    Article  CAS  PubMed  Google Scholar 

  43. • Ponikowski P, Van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657–68. Demonstrates that in patients with HFrEF and iron-deficiency, those treated with ferric carboxymaltose responded with higher functional capacity, symptoms, and quality of life outcomes compared with a placebo condition at 1-year follow-up

  44. • Thirapatarapong W, Thomas RJ, Pack Q, Sharma S, Squires RW. Commercial insurance coverage for outpatient cardiac rehabilitation in patients with heart failure in the United States. J Cardiopulm Rehabil Prev. 2014;34(6):386–9. https://doi.org/10.1097/HCR.0000000000000060. Presents data showing that many, but not all, US healthcare insurers provide coverage for patients with HF to participate in outpatient cardiac rehabilitation therapy, suggesting coverage rates for this form of medical therapy will increase in the future

  45. Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol. 2013;61(6):599–610. https://doi.org/10.1016/j.jacc.2012.08.1021.

    Article  CAS  PubMed  Google Scholar 

  46. Okita K, Yonezawa K, Nishijima H, Hanada A, Ohtsubo M, Kohya T, et al. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation. 1998;98(18):1886–91.

    Article  CAS  PubMed  Google Scholar 

  47. •• Haykowsky MJ, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol. 2014;113(7):1211–6. https://doi.org/10.1016/j.amjcard.2013.12.031. Demonstrates skeletal muscle pathophysiology affecting reduced oxidative capacity may play a critical role in exercise intolerance in patients with HFpEF

  48. Keller-Ross ML, Johnson BD, Carter RE, Joyner MJ, Eisenach JH, Curry TB, et al. Improved ventilatory efficiency with locomotor muscle afferent inhibition is strongly associated with leg composition in heart failure. Int J Cardiol. 2016;202:159–66. https://doi.org/10.1016/j.ijcard.2015.08.212.

    Article  PubMed  Google Scholar 

  49. Toth MJ, Miller MS, Ward KA, Ades PA. Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol (1985). 2012;112(11):1864–74. https://doi.org/10.1152/japplphysiol.01591.2011.

    Article  CAS  Google Scholar 

  50. •• Southern WM, Ryan TE, Kepple K, Murrow JR, Nilsson KR, McCully KK. Reduced skeletal muscle oxidative capacity and impaired training adaptations in heart failure. Physiol Rep. 2015;3(4):e12353. 10.14814/phy2.12353. Demonstrates skeletal muscle pathophysiology unique to heart failure affects training responsiveness to structured exercise training therapy, suggesting not all patients may demonstrate increased oxidative capacity following this medical care approach

  51. Toth MJ, Shaw AO, Miller MS, VanBuren P, LeWinter MM, Maughan DW, et al. Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol. 2010;143(3):276–82.

    Article  PubMed  Google Scholar 

  52. Manetos C, Dimopoulos S, Tzanis G, Vakrou S, Tasoulis A, Kapelios C, et al. Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure. J Heart Lung Transplant. 2011;30(12):1403–8. https://doi.org/10.1016/j.healun.2011.08.020.

    Article  PubMed  Google Scholar 

  53. Olson TP, Joyner MJ, Dietz NM, Eisenach JH, Curry TB, Johnson BD. Effects of respiratory muscle work on blood flow distribution during exercise in heart failure. J Physiol. 2010;588(Pt 13):2487–501. https://doi.org/10.1113/jphysiol.2009.186056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Springer J, Anker SD. Publication trends in cachexia and sarcopenia in elderly heart failure patients. Wien Klin Wochenschr. 2016;128(Suppl 7):446–54. https://doi.org/10.1007/s00508-016-1126-2.

    Article  PubMed  Google Scholar 

  55. Ponikowski PP, Chua TP, Francis DP, Capucci A, Coats AJ, Piepoli MF. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation. 2001;104(19):2324–30.

    Article  CAS  PubMed  Google Scholar 

  56. Scott AC, Wensel R, Davos CH, Georgiadou P, Kemp M, Hooper J, et al. Skeletal muscle reflex in heart failure patients: role of hydrogen. Circulation. 2003;107(2):300–6.

    Article  CAS  PubMed  Google Scholar 

  57. Scott AC, Wensel R, Davos CH, Kemp M, Kaczmarek A, Hooper J, et al. Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control. Circulation. 2002;106(2):214–20.

    Article  CAS  PubMed  Google Scholar 

  58. Van Iterson EH, Snyder EM, Johnson BD, Olson TP. Influence of the metaboreflex on pulmonary vascular capacitance in heart failure. Med Sci Sports Exerc. 2016;48(3):353–62. https://doi.org/10.1249/MSS.0000000000000775.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Van Iterson EH, Snyder EM, Joyner MJ, Johnson BD, Olson TP. Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: influence on circulatory power and pulmonary vascular capacitance. Int J Cardiol. 2015;201:384–93. https://doi.org/10.1016/j.ijcard.2015.08.101.

    Article  PubMed  PubMed Central  Google Scholar 

  60. American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2013.

    Google Scholar 

  61. American Association of Cardiovascular Pulmonary Rehabilitation. Guidelines for cardia rehabilitation and secondary prevention programs-(with web resource). Champaign: Human Kinetics; 2013.

    Google Scholar 

  62. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ades PA, Keteyian SJ, Balady GJ, Houston-Miller N, Kitzman DW, Mancini DM, et al. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail. 2013;1(6):540–7.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Smart NA, Dieberg G, Giallauria F. Intermittent versus continuous exercise training in chronic heart failure: a meta-analysis. Int J Cardiol. 2013;166(2):352–8. https://doi.org/10.1016/j.ijcard.2011.10.075.

    Article  PubMed  Google Scholar 

  65. Collaborative E. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004;328(7433):189.

    Article  Google Scholar 

  66. Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, Ebrahim S, et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail. 2010;12(7):706–15. https://doi.org/10.1093/eurjhf/hfq056.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol. 2007;49(24):2329–36. https://doi.org/10.1016/j.jacc.2007.02.055.

    Article  PubMed  Google Scholar 

  68. Giannuzzi P, Temporelli PL, Corrà U, Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure. Circulation. 2003;108(5):554–9.

    Article  PubMed  Google Scholar 

  69. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA. 2000;283(23):3095–101.

    Article  CAS  PubMed  Google Scholar 

  70. Taylor RS, Davies EJ, Dalal HM, Davis R, Doherty P, Cooper C, et al. Effects of exercise training for heart failure with preserved ejection fraction: a systematic review and meta-analysis of comparative studies. Int J Cardiol. 2012;162(1):6–13. https://doi.org/10.1016/j.ijcard.2012.05.070.

    Article  PubMed  Google Scholar 

  71. Mezzani A, Grassi B, Jones AM, Giordano A, Corrà U, Porcelli S, et al. Speeding of pulmonary VO 2 on-kinetics by light-to-moderate-intensity aerobic exercise training in chronic heart failure: clinical and pathophysiological correlates. Int J Cardiol. 2013;167(5):2189–95.

    Article  PubMed  Google Scholar 

  72. van Tol BA, Huijsmans RJ, Kroon DW, Schothorst M, Kwakkel G. Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis. Eur J Heart Fail. 2006;8(8):841–50. https://doi.org/10.1016/j.ejheart.2006.02.013.

    Article  PubMed  Google Scholar 

  73. Oka RK, De Marco T, Haskell WL, Botvinick E, Dae MW, Bolen K, et al. Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. Am J Cardiol. 2000;85(3):365–9.

    Article  CAS  PubMed  Google Scholar 

  74. Pu CT, Johnson MT, Forman DE, Hausdorff JM, Roubenoff R, Foldvari M, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol. 2001;90(6):2341–50.

    CAS  PubMed  Google Scholar 

  75. Selig SE, Carey MF, Menzies DG, Patterson J, Geerling RH, Williams AD, et al. Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow. J Card Fail. 2004;10(1):21–30.

    Article  PubMed  Google Scholar 

  76. Magnusson G, Gordon A, Kaijser L, Sylven C, Isberg B, Karpakka J, et al. High intensity knee extensor training, in patients with chronic heart failure. Eur Heart J. 1996;17(7):1048–55.

    Article  CAS  PubMed  Google Scholar 

  77. Tyni-Lenné R, Dencker K, Gordon A, Jansson E, Sylvén C. Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure. Eur J Heart Fail. 2001;3(1):47–52.

    Article  PubMed  Google Scholar 

  78. Feiereisen P, Delagardelle C, Vaillant M, Lasar Y, Beissel J. Is strength training the more efficient training modality in chronic heart failure? Med Sci Sports Exerc. 2007;39(11):1910–7.

    Article  PubMed  Google Scholar 

  79. Maiorana AJ, Naylor LH, Exterkate A, Swart A, Thijssen DH, Lam K, et al. The impact of exercise training on conduit artery wall thickness and remodeling in chronic heart failure patients. Hypertension. 2011;57(1):56–62.

    Article  CAS  PubMed  Google Scholar 

  80. Savage P, Shaw AO, Miller MS, VanBuren P, LeWinter MM, Ades PA, et al. Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc. 2011;43(8):1379.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Maiorana A, O'Driscoll G, Dembo L, Cheetham C, Goodman C, Taylor R, et al. Effect of aerobic and resistance exercise training on vascular function in heart failure. Am J Phys Heart Circ Phys. 2000;279(4):H1999–2005.

    CAS  Google Scholar 

  82. Delagardelle C, Feiereisen P, Autier P, Shita R, Krecke R, Beissel J. Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc. 2002;34(12):1868–72.

    Article  PubMed  Google Scholar 

  83. Bouchla A, Karatzanos E, Dimopoulos S, Tasoulis A, Agapitou V, Diakos N, et al. The addition of strength training to aerobic interval training: effects on muscle strength and body composition in CHF patients. J Cardiopulm Rehabil Prev. 2011;31(1):47–51.

    Article  PubMed  Google Scholar 

  84. Georgantas A, Dimopoulos S, Tasoulis A, Karatzanos E, Pantsios C, Agapitou V, et al. Beneficial effects of combined exercise training on early recovery cardiopulmonary exercise testing indices in patients with chronic heart failure. J Cardiopulm Rehabil Prev. 2014;34(6):378–85.

    Article  PubMed  Google Scholar 

  85. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, et al. Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm Rehabil Prev. 2009;29(6):385–91.

    Article  PubMed  Google Scholar 

  86. • Zamani P, Tan V, Soto-Calderon H, Beraun M, Brandimarto JA, Trieu L, et al. Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction. Circ Res. 2017;120(7):1151–61. https://doi.org/10.1161/CIRCRESAHA.116.309832. Provides follow-up inorganic nitrate dosing evidence based on this group's original study suggesting the favorable effects of transient inorganic nitrate supplementation for up to 2 weeks leads to improved exercise tolerance in patients with HFpEF

  87. • Borlaug BA, Melenovsky V, Koepp KE. Inhaled sodium nitrite improves rest and exercise hemodynamics in heart failure with preserved ejection fraction. Circ Res. 2016;119(7):880–6. https://doi.org/10.1161/CIRCRESAHA.116.309184. Suggests supplementation with inhaled inorganic nitrite prior to exercise leads to improved central hemodynamic function followed by improved exercise capacity in patients with HFpEF

  88. • Chirinos JA, Londono-Hoyos F, Zamani P, Beraun M, Haines P, Vasim I, et al. Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction. Eur J Heart Fail. 2017; https://doi.org/10.1002/ejhf.885. Provides evidence to suggest compared with organic nitrate supplementation, inorganic nitrate supplementation on a more consistent basis leads to improved arterial hemodynamic function as a mechanism to explain improved exercise capacity using this approach in patients with HFpEF

  89. • Eggebeen J, Kim-Shapiro DB, Haykowsky M, Morgan TM, Basu S, Brubaker P, et al. One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2016;4(6):428–37. Demonstrates extended, but not acute, dosing of inorganic nitrate for up to one week in duration leads to improved submaximal exercise hemodynamics and tolerance in patients with HFpEF

  90. • Coggan AR, Leibowitz JL, Spearie CA, Kadkhodayan A, Thomas DP, Ramamurthy S, et al. Acute dietary nitrate intake improves muscle contractile function in patients with heart failure clinical perspective. Circ Heart Fail. 2015;8(5):914–20. Using a non-aerobic exercise paradigm, this study demonstrates inorganic nitrate supplementation compared with a cross-over placebo condition leads to improved peak knee extensor power and velocity without effects of blood pressure in patients with HFpEF

  91. •• Shaltout HA, Eggebeen J, Marsh AP, Brubaker PH, Laurienti PJ, Burdette JH, et al. Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction. Nitric Oxide. 2017; https://doi.org/10.1016/j.niox.2017.05.005. By contrast to cross-sectional studies of the nitrate-nitrite-NO pathway in patients with HFpEF, this study demonstrates that while structured exercise training therapy leads to improve exercise tolerance, the addition of inorganic nitrate supplementation to exercise training does not affect physiological outcomes in these patients

  92. • Hirai DM, Zelt JT, Jones JH, Castanhas LG, Bentley RF, Earle W, et al. Dietary nitrate supplementation and exercise tolerance in patients with heart failure with reduced ejection fraction. Am J Phys Regul Integr Comp Phys. 2017;312(1):R13–22. Using a double blind placebo controlled cross over design, this study presents evidence to suggest that supplementation with inorganic nitrate for up to 9 days demonstrates no effects on key central and peripheral components in the O2 transport chain associated with changes in exercise tolerance in patients with HFrEF

  93. Amann M, Venturelli M, Ives SJ, Morgan DE, Gmelch B, Witman MA, et al. Group III/IV muscle afferents impair limb blood in patients with chronic heart failure. Int J Cardiol. 2014;174(2):368–75. https://doi.org/10.1016/j.ijcard.2014.04.157.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA

    Erik H. Van Iterson PhD, MS, MA & Thomas P. Olson PhD

Authors
  1. Erik H. Van Iterson PhD, MS, MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas P. Olson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erik H. Van Iterson PhD, MS, MA.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Heart Failure

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Iterson, E.H., Olson, T.P. Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training. Curr Treat Options Cardio Med 19, 87 (2017). https://doi.org/10.1007/s11936-017-0585-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-017-0585-8

Keywords

Search

Navigation